The current sections of Revista Hematología are:
- Original articles
- My opinion
- Anatomo-clinic discussion of the hematology fellowships
- Editorial
- Updates and/or reviews
- Pediatric hematology
- New drugs in hematology
- Brief communications
- Laboratory
- History of hematology
- Case reports
- Images in hematology
- Letters to the Editor
- Narrative Hematology
1) Original articles must be unpublished. They should not have been submitted simultaneously to another
HEMATOLOGY
JOURNAL
REGULATIONS
journal without knowing the decision of acceptance or denial from Revista Hematología.
The articles should be in Word format, double-spaced, in Times New Roman font 12, with wide margins of 3cm with a maximum of 4,000 words,
including tables and references. All illustrations, figures and tables and their respective legend, should be placed in the appropriate places in the text,
instead of at the end.
The articles arrangement should be as follows:
1. a) Cover: It will include the following items:
- Title (both in English and Spanish): with no abbreviations; it will be concise and precise.
- Authors:
• The list of authors should be included in a separate line, separated by commas, beginning with the complete last name and the initials of the
name.
• Institutional affiliation: it will include the institution name (without abbreviations) where the work has been carried out for each author.
Example:
Pérez V1; González C2
1 Servicio Hematología, Hospital Milstein. Buenos Aires, Argentina
2 Servicio de Hematología, Hospital Fernández. Buenos Aires, Argentina
City, country of origin, and e-mail of the responsible author.
Authorship: Revista Hematología adheres to the International Committee of Medical Journal Editors (ICMJE) guidelines, which in the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals delimits that to get the authorship of the studies, each of the participants must meet the following criteria:
• They must have made substantial contributions to the conception and design of the study or the acquisition, analysis, or interpretation of its data.
• They must have participated in drafting the work or revising it critically for important intellectual content.
• They must have provided the final approval of the version to be published.
• They must have agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part
of the work are appropriately investigated and resolved.
To the effects of complying with this requirement, the cover must include the following statement under the list of authors:
‘The authors have made a substantial contribution to the conception or design of the work, and data acquisition, analysis, or interpretation. They have
participated in the article drafting or the critical revision of its intellectual content. They have agreed to the final version of the manuscript and can
defend every aspect of the manuscript to guarantee that all the questions related to the accuracy or integrity of its content have been appropriately
investigated and resolved.’
Note: The statement of authorship should only be included in research articles with multiple authors, but not in those with only one author.
• If necessary, above the authorship declaration you can include the persons or institutions that have participated in the study who do not comply
with the four mentioned criteria but that contributed to its development. They should be identified by name and last name/s or name of the
institution, specifying the specific contribution to the research work.
1. b) Summary and keywords
- Summary:
• Both in Spanish and English.
• Structure: Introduction, Material and Methodology, Results and Discussion.
• Length: up to 400 words.
- Keywords:
• Both in Spanish and English.
• Quantity: between 3 and 5.
• Use terms from the Index Medicus Medical Subjects Headings.
c) Introduction: Summary of the state of the art of the topic and the goals of the work.
d) Materials and Methodology: It must detail the population used (control groups and patients), the methodology employed, and the statistical methods
used to evaluate the results. This section should include a statement indicating the approval of the Institutional Ethics Committee or competent
authority, as well as the written informed consent obtained from each patient, and that the study protocol was carried out following the ethical standards
of the 1975 Declaration of Helsinki.
e) Results: They should be clearly expressed in quantitative form, using numeric values (in the usual international units), tables, and/or graphs. Tables
that occupy more than one page will not be accepted.
Abbreviations and symbols must be specified in the text or under the tables.
f) Discussion: It analyses the results and the facts directly related to them, the relationship between them and the initially proposed goal, and their
comparison with the previously established knowledge.
g) Bibliographic references:
The authors are responsible for checking the accuracy and integrity of the references. Only references mentioned in the article will be included, in
sequential numerical order. The names of the authors must be listed at the beginning separated by commas, first the last name, then the initials of the
names. If there are more than six authors, only the first three will be mentioned, followed by the acronym et al. Then, write the article title and the
abbreviated name of the journal, according to the Medicus Index; year of publication, semicolon, volume number colon, first page, hyphen, last page.
Include the DOI, if applicable.
Example: Kaldor JM, Day EN, Clarke EA, et al. Leukemia following Hodgkin’s disease. N Engl. J Med 1990; 322:7-13. https://doi.org/15.1555/S0363-
5023(10)8111-0
In the case of books, the name of the author/s, title of the book, publisher/s, year of publication, pages separated by a hyphen, adding the edition number
if it is not the first edition, publishing house, and city. Example: Hughes TP and Goidman JM. Chronic myeloid leukemia.
Hematology: Basic Principles and Practice. R. Hoffman, El Benz, Sj Shatill, B Ftirie y EJCoben 1991, p 854-869. Churchill Livingstone, Edinburgh.
Supporting data
To quote this type of data, located in the Data depository, the following format must be used:
López Cosar, H., Bentmiglia, C., Alfonsín, M., (2020). Controlled study between the traditional coagulometric method and a portable device in the measurement of the normalized international ratio and medical decision-making. [Dataset] Version from June 22, 2021. SciELo Data. (link provided
for the repository that will include a persistent digital object identifier, such as handle, DOI, or other)
References must be visible in the text in parentheses, and subscript. The journal adopts the criteria established by the APA Standards (www.normasapa.com)
2) My opinion section is destined to express an expert opinion about a controversial topic commissioned by the Editorial Committee.
Disagreement with this opinion can be expressed through the Letters to the Editor section. The length should not exceed 3,000 words. They should follow
the graphic format of original articles.
3) Anatomo-clinic studies should be written with the same graphic format and follow the same guidelines as the original articles.
4) Editorials will be commissioned by the Editorial Committee. They will have a title and text with monograph characteristics, if possible, with a maximum
length of 2,000 words, up to 5 bibliographic references, name of the author, address, zip code, and e-mail address.
5) Updates and/or revisions should follow the graphic format of the original articles. The length should not exceed 5,000 words.
6) Pediatric Hematology section: It will be intended for reviews of hematological topics and clinical cases in children. They should follow the graphic
format of original articles.
7) New drugs in Hematology section will be an update on new drugs used by this specialty. They will be commissioned by the Editorial Committee. The
length should not exceed 3,000 words. They should follow the graphic format of original articles.
8) Brief communications section should follow the graphic format of the original articles. The length should not exceed 2,000 words, and the abstract
should not exceed 200 words.
9) Laboratory in Hematology is intended to perform a datasheet of a trial used in Hematology laboratories. It will be commissioned by the Editorial Committee.
It should include an introduction, rationale for the trial, pre-analytical and analytical characteristics, reference values and their clinical benefit, and
up to 4 bibliographic references. The length should not exceed 3,000 words. They should follow the graphic format of original articles.
10) The History of Hematology section should follow the graphic format of original articles and it is intended to disseminate the evolution of Hematology
in Argentina. The length should not exceed 4,000 words.
11) Case report. In this section, there is a maximum of 8 bibliographic references allowed. They should follow the graphic format of original articles.
12) Images in Hematology: will consist of high-quality colored photographic material, intended to expose topics of diverse nature.
It should not exceed 1,000 words and should be developed in the following order: Title, concise text, image, and name of the authors. Up to four bibliographic references can be added. They should follow the graphic format of the original articles.
13) In the Letters to the Editor section, opinions on clinical situations and experiences that can be related or not with the articles published in Revista will
be published, with a critical, objective, and/or educational criterion, accepting the right to reply in case of an opinion about any published article. The length
should not exceed 1,000 words (up to 4 bibliographic references).
14) The Narrative Hematology section should follow the graphic format as original articles. This section will accept submissions for consideration that fall within the field of narrative medicine with a connection to hematology. Texts that incorporate aspects of medical humanities in a format related to hematology concepts will also be considered. Manuscripts should have a maximum length of 5,000 words and no more than 50 references. Submissions must be in Spanish, and those who wish may submit an English translation of their manuscript for online publication.
Conflicts of interest:
Authors are solely responsible for the content, statements, and authorship of the published articles, and they must clarify in writing if there is any conflict of interest. All participants must include their disclosure in a footnote. From the first edition in 2013, all presentations
in Revista Hematología must include a final paragraph in the manuscript that specifies the conflict of interest statement following the attached model.
It is NOT allowed to send to another journal the work submitted to Hematologia. The adapted model of conflict of interest proposed
by the SAH Board of Directors is based on that of the American Society of Hematology and bears the same format as many prestigious
journals of our specialty. We refer to all current activities and those carried out in the last year.
Different categories of conflicts of interest are recognized and detailed below:
1) Employee
2) Consultant
3) Share Ownership
4) Research funds for own studies (The standard does NOT include multicenter, national, or international Phase II to IV research protocols)
5) Conference fees (Speaker)
6) Advisory Board Member
Images:
Images must be submitted in jpg format, 300 dpi resolution, they can be sent in color.
Copyright Notice
All the material published in Revista Hematología will be transferred to the Argentine Society of Hematology. Under the Copyright Act (Act 11723), authors of each accepted work will receive a transfer of copyright form, which must be signed before publication. The authors should keep a copy of the original since the journal is not responsible for damages or loss of the submitted material. The authors should
send an electronic version to the email: revista@sah.org.ar
Privacy Statement
The names and email addresses entered in this journal will be used exclusively for the stated purposes and will not be shared with other parties nor used for other purposes.
Code of Ethics
Hematología applies its publishing policy on ethical aspects of scientific publications following the Committee on Publication Ethics
(COPE).
In the event of clinical studies performed on human subjects, the procedures carried out must follow the Ethics standard explicitly from the responsible committee in human experimentation, institutional or regional, and with the 1975 Declaration of Helsinki, amended in
1983 and revised in 1989, which should be explicitly stated in the methodology of the work.
Do not use the names of patients, their initials, or hospital number, especially in the illustrative material.
All research that includes experimental animals must follow the indications in the ‘Guide for the care and use of laboratory animals’
(http://www.nap.edu/readingroom/books/labrats/) from the US National Academy of Sciences and the American Physiological Society
(APS) (http://www.the-aps.org/committees/animal/index.htm).
Articles that do not comply with the Code of Ethics will not be considered for publication.
Animal models
If works in animal models are accepted, the authors should send the appropriate certificate of approval from the project issued by CICUAL (Institutional Committee for the Care and Use of Laboratory Animals).
You can access the instructions for using this platform by clicking here.